Filter Results
:
(254)
Show Results For
-
All HBS Web
(254)
- People (1)
- News (38)
- Research (110)
- Events (2)
- Multimedia (1)
- Faculty Publications (35)
Show Results For
-
All HBS Web
(254)
- People (1)
- News (38)
- Research (110)
- Events (2)
- Multimedia (1)
- Faculty Publications (35)
- 15 Jul 2013
- Research & Ideas
Five Imperatives for Improving Health Care
conference and survey from Harvard's business and medical schools may prove particularly timely. Delivered by the Forum on Healthcare Innovation, which was formed last year with encouragement from the respective deans of the two...
View Details
- Article
Comparative Costs of Advanced Proton and Photon Radiation Therapies: Lessons from Time-driven Activity-based Costing in Head and Neck Cancer
By: Nikhil G. Thaker, Steven J. Frank and Thomas W. Feeley
Time-driven activity-based costing (TDABC) is an innovative costing tool in healthcare that can be used to directly compare the true cost of competing technologies over the full care cycle. Rather than only comparing therapeutic effectiveness over a limited number of...
View Details
Keywords:
Head And Neck Cancer;
IMRT;
Proton Therapy;
Time-Driven ABC;
Information Technology;
Activity Based Costing and Management;
Medical Specialties
Thaker, Nikhil G., Steven J. Frank, and Thomas W. Feeley. "Comparative Costs of Advanced Proton and Photon Radiation Therapies: Lessons from Time-driven Activity-based Costing in Head and Neck Cancer." Journal of Comparative Effectiveness Research 4, no. 4 (2015): 297–301.
- 19 May 2020
- Video
Getting to Know 2020 Class Day Student Speaker Claire Wagner
- September 17, 2020
- Article
Protecting Vulnerable Older Patients during the Pandemic
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
Older people (70 years and older) with multiple chronic conditions have the highest risk of being hospitalized and dying from COVID-19. The recent COVID-19 pandemic has highlighted how a strong primary care system can play an important role in protecting this group of...
View Details
Keywords:
COVID-19;
High-risk Patients;
Primary Care;
Health Pandemics;
Health Care and Treatment;
Innovation and Invention;
Demographics;
Age
Ikram, Umar, Susanna Gallani, Jose F. Figueroa, and Thomas W. Feeley. "Protecting Vulnerable Older Patients during the Pandemic." NEJM Catalyst (September 17, 2020).
- December 2022
- Article
Cost Standard Set Program: Moving Forward to Standardization of Cost Assessment Based on Clinical Condition
By: Anna Paula Beck da Silva Etges, Richard D. Urman, Anne Geubelle, Robert Kaplan and Carisi Anne Polanczyk
This communication announces the International Cost Standard Set Program. Its goal is to establish global standardized frameworks for measuring the costs of treating specific clinical conditions. A scientific committee, including 16 international healthcare cost...
View Details
Keywords:
Time-Driven Activity-Based Costing;
Value-based Health Care;
Cost;
Health Care and Treatment;
Activity Based Costing and Management;
Health Industry
da Silva Etges, Anna Paula Beck, Richard D. Urman, Anne Geubelle, Robert Kaplan, and Carisi Anne Polanczyk. "Cost Standard Set Program: Moving Forward to Standardization of Cost Assessment Based on Clinical Condition." Journal of Comparative Effectiveness Research 11, no. 17 (December 2022): 1219–1223.
- June 2010 (Revised December 2019)
- Case
Piramal e-Swasthya (A): Attempting Big Changes for Small Places - in India and Beyond
By: Rosabeth M. Kanter and Matthew Bird
Anand Piramal and his team sought to "democratize healthcare" in India through the development of a new service delivery model. If Henry Ford could build and deliver cars to everyone in the United States, Piramal thought, then why can't India deliver healthcare to the...
View Details
Keywords:
Health Care and Treatment;
Service Delivery;
Social Entrepreneurship;
Change Management;
Emerging Markets;
Health Industry;
India
Kanter, Rosabeth M., and Matthew Bird. "Piramal e-Swasthya (A): Attempting Big Changes for Small Places - in India and Beyond." Harvard Business School Case 310-134, June 2010. (Revised December 2019.)
- 04 Mar 2022
- HBS Seminar
Michael Chu & Bob Kaplan, HBS
- 12 PM – 1 PM EST, 10 Nov 2016
- Webinars: Trending@HBS
Impact Investing: Challenges and Opportunities
Never has there been a time when so many believed in both the ability and responsibility of the private sector to combat the world's greatest social challengesfrom poverty to climate change to accessible health care. Recent years have seen the creation of thousands of...
View Details
- Article
The Implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on Cancer Care Delivery
By: Heidi W. Albright, Mark Moreno, Thomas W. Feeley, Ronald Walters, Marc Samuels, Alissa Pereira and Thomas W. Burke
In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. This legislation attempts to address cost control and improve the quality of healthcare in the United States. Cancer is a...
View Details
Keywords:
Health Care Policy;
Health Care;
Cancer Care In The U.S.;
Cancer Care Services;
Health;
Law;
Quality;
Health Industry;
North and Central America
Albright, Heidi W., Mark Moreno, Thomas W. Feeley, Ronald Walters, Marc Samuels, Alissa Pereira, and Thomas W. Burke. "The Implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on Cancer Care Delivery." Cancer 117, no. 8 (April 15, 2011): 1564–1574.
- 23 Mar 2023
- HBS Seminar
Tinglong Dai, Johns Hopkins
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical...
View Details
Keywords:
Health;
Pharmaceutical Industry;
Biotech;
Marketing;
Health Care and Treatment;
Biotechnology Industry;
England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- 20 Dec 2022
- Blog Post
7 Resolutions for Recruiting in the New Year
Whether your company is manufacturing farming equipment, advising Fortune 500 companies, or developing the next healthcare innovation, you know that the success of your business starts with people. Great teams drive great results and to...
View Details
Keywords:
All Industries
- Article
Is Saving Lives Your Task or God's?: Religiosity, Belief in God, and Moral Judgment
By: Netta Barak-Corren and Max Bazerman
Should a Catholic hospital abort a life-threatening pregnancy or let a pregnant woman die? Should a religious employer allow his employees access to contraceptives or break with healthcare legislation? People and organizations of faith often face moral decisions that...
View Details
Keywords:
Normative Conflict;
Inaction;
Indirectness;
Deontology;
Utilitarianism;
Sunday Effect;
Religion;
Moral Sensibility;
Decisions;
Judgments
Barak-Corren, Netta, and Max Bazerman. "Is Saving Lives Your Task or God's? Religiosity, Belief in God, and Moral Judgment." Judgment and Decision Making 12, no. 3 (May 2017): 280–296.
- 2022
- Working Paper
Rethinking Explainability as a Dialogue: A Practitioner's Perspective
By: Himabindu Lakkaraju, Dylan Slack, Yuxin Chen, Chenhao Tan and Sameer Singh
As practitioners increasingly deploy machine learning models in critical domains such as healthcare, finance, and policy, it becomes vital to ensure that domain experts function effectively alongside these models. Explainability is one way to bridge the gap between...
View Details
Keywords:
Natural Language Conversations;
AI and Machine Learning;
Experience and Expertise;
Interactive Communication;
Business and Stakeholder Relations
Lakkaraju, Himabindu, Dylan Slack, Yuxin Chen, Chenhao Tan, and Sameer Singh. "Rethinking Explainability as a Dialogue: A Practitioner's Perspective." Working Paper, 2022.
- November 2022
- Case
The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales
By: Regina E. Herzlinger and Tiffany Farrell
Can an online, direct-to-consumer pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous...
View Details
Keywords:
DTC;
Internet and the Web;
Marketing Channels;
Customer Value and Value Chain;
Governing Rules, Regulations, and Reforms;
Competitive Strategy;
Service Delivery;
Growth and Development Strategy;
Pharmaceutical Industry;
Health Industry;
Retail Industry
Herzlinger, Regina E., and Tiffany Farrell. "The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales." Harvard Business School Case 323-031, November 2022.
- 22 Nov 2019
- Blog Post
Avant Ski Makes Turns in Ski Media Objectivity
It seems like a former life: Investment banking at Goldman Sachs. Healthcare equity research at Citi. Boutique leadership consulting for aspiring CEOs. While Morristown, New Jersey, native Alli Widman (MBA 2009) cut her teeth in finance...
View Details
- Article
The Relationship Between Workplace Stressors and Mortality and Health Costs in the United States
By: Joel Goh, Jeffrey Pfeffer and Stefanos A. Zenios
Even though epidemiological evidence links specific workplace stressors to health outcomes, the aggregate contribution of these factors to overall mortality and health spending in the United States is not known. In this paper, we build a model to estimate the excess...
View Details
Goh, Joel, Jeffrey Pfeffer, and Stefanos A. Zenios. "The Relationship Between Workplace Stressors and Mortality and Health Costs in the United States." Management Science 62, no. 2 (February 2016): 608–628.
- Web
PhD Programs - Doctoral
rigorous, relevant research that influences practice. Our doctoral students work with faculty and access resources throughout HBS and Harvard University. The PhD program curriculum requires coursework at HBS and other Harvard discipline...
View Details
- Web
Design Thinking Course | HBS Online
subject area to earn a Certificate of Specialization Learn More about what you earn Syllabus 7 Modules, 40-50 Hours Download full syllabus This course features access to an AI course assistant bot, in beta release, to facilitate your...
View Details
- Web
Faculty & Advisors - MBA
University Professor at Harvard University, Co-Director of Harvard Stem Cell Institute Program Advisors Students have access to a network of program advisors who serve as mentors, speakers, and career advisors for the community....
View Details